Curiance Pharma Private Limited
This company trades and manufactures pharmaceutical products, including medicines, supplements, and healthcare items.
2017 | Nashik, Maharashtra (India) | Active
Curiance Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -34.48%
- Profit Growth -239.52%
- Ebitda -314.52%
- Net Worth -351.14%
- Total Assets -72.35%
About Curiance Pharma
Curiance Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 September 2017 (Seven years and five months 1 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhishek Ranade and Manoj Sharma serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2017PTC300248
- Company No.
300248
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Curiance Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Ranade  | Director | 19-Feb-2020 | Current |
| Manoj Sharma | Director | 19-Feb-2020 | Current |
Financial Performance of Curiance Pharma.
Curiance Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.48% decrease. The company also saw a substantial fall in profitability, with a 239.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 351.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curiance Pharma?
Unlock access to Curiance Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Curiance Pharma?
Unlock and access historical data on people associated with Curiance Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curiance Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curiance Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
